Literature DB >> 23628208

GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis.

S Mundiyanapurath1, S Jarius, C Probst, W Stöcker, B Wildemann, J Bösel.   

Abstract

BACKGROUND: Gamma-aminobutyric-acid B (GABA-B)-receptor encephalitis represents a novel entity among autoimmune CNS disorders. Most cases are characterised by limbic encephalitis. CASE REPORT: A 63-year-old patient presented with acute vertigo, nausea and vomiting, facial palsy and dysarthria. He developed dysphagia, gait ataxia and, finally, respiratory failure. Antibodies to GABA-B receptors were positive and declined under treatment with intravenous methylprednisolone and plasma exchange, followed by clinical improvement and stabilisation. Broad tumour screening revealed oesophageal carcinoma.
CONCLUSION: The spectrum of neurological manifestations and tumours associated with the paraneoplastic variant of anti-GABA-B-receptor encephalitis may be broader than previously reported.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23628208     DOI: 10.1016/j.jneuroim.2013.04.004

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  19 in total

Review 1.  Autoimmune encephalopathies.

Authors:  Frank Leypoldt; Thaís Armangue; Josep Dalmau
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

2.  GABAB receptor autoantibody frequency in service serologic evaluation.

Authors:  Oliver J Jeffery; Vanda A Lennon; Sean J Pittock; Jeremy K Gregory; Jeffrey W Britton; Andrew McKeon
Journal:  Neurology       Date:  2013-08-07       Impact factor: 9.910

Review 3.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

4.  Progressive limbic encephalopathy: Problems and prospects.

Authors:  Sadanandavalli Retnaswami Chandra; Roopa Seshadri; Yasha Chikabasaviah; Thomas Gregor Issac
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383

5.  Autoimmune encephalitis with GABAB antibodies, thymoma, and GABAB receptor thymic expression.

Authors:  Harry Alexopoulos; Ioannis E Dagklis; Sofia Akrivou; Sevasti Bostantjopoulou; Marinos C Dalakas
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-10-29

Review 6.  The Laboratory Diagnosis of Autoimmune Encephalitis.

Authors:  Sang Kun Lee; Soon-Tae Lee
Journal:  J Epilepsy Res       Date:  2016-12-31

Review 7.  Autoimmune Neurogenic Dysphagia.

Authors:  Panos Stathopoulos; Marinos C Dalakas
Journal:  Dysphagia       Date:  2021-07-05       Impact factor: 2.733

Review 8.  Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.

Authors:  James Varley; Angela Vincent; Sarosh R Irani
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849

9.  Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.

Authors:  Sven Jarius; Madeleine Scharf; Nora Begemann; Winfried Stöcker; Christian Probst; Irina I Serysheva; Sigrun Nagel; Francesc Graus; Dimitri Psimaras; Brigitte Wildemann; Lars Komorowski
Journal:  J Neuroinflammation       Date:  2014-12-11       Impact factor: 8.322

10.  Limbic Encephalitis Associated with Anti-γ-aminobutyric Acid B Receptor Antibodies: A Case Series from China.

Authors:  Hong-Zhi Guan; Hai-Tao Ren; Xun-Zhe Yang; Qiang Lu; Bin Peng; Yi-Cheng Zhu; Xiao-Qiu Shao; Yong-Qiang Hu; Dong Zhou; Li-Ying Cui
Journal:  Chin Med J (Engl)       Date:  2015-11-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.